共 50 条
- [21] Pharmacogenetic association of KCNJ11 (E23K) variant with therapeutic response to sulphonylurea (glibenclamide) in Iranian patients International Journal of Diabetes in Developing Countries, 2015, 35 : 630 - 631
- [24] The KCNJ11 E23K Polymorphism and Progression of Glycaemia in Southern Chinese: A Long-Term Prospective Study PLOS ONE, 2011, 6 (12):
- [25] KCNJ11 E23K variant is associated with the therapeutic effect of sulphonylureas in Chinese type 2 diabetic patients CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2014, 41 (10): : 748 - 754
- [27] Frequency of the E23K polymorphism of the KCNJ11 gene in children born small for gestational age and its influence on auxological and metabolic parameters in the prepubertal period JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2013, 26 (5-6): : 457 - 462
- [28] Association of KCNJ11 E23K/rs5219 Gene Polymorphism with Type 2 Diabetes and Diabetes-Related Cardiovascular Disease DIABETES METABOLIC SYNDROME AND OBESITY, 2025, 18 : 653 - 661
- [30] Kir6.2 (KCNJ11) E23K variant in Type 2 diabetes in Italians OBESITY AND METABOLISM-MILAN, 2007, 3 (02): : 97 - 98